Premium
Effects of prescribing 1,000 versus 1,500 kilocalories per day in the behavioral treatment of obesity: A randomized trial
Author(s) -
Nackers Lisa M.,
Middleton Kathryn R.,
Dubyak Pamela J.,
Daniels Michael J.,
Anton Stephen D.,
Perri Michael G.
Publication year - 2013
Publication title -
obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.438
H-Index - 199
eISSN - 1930-739X
pISSN - 1930-7381
DOI - 10.1002/oby.20439
Subject(s) - medicine , calorie , obesity , weight loss , randomized controlled trial , medical prescription , weight management , low calorie diet , pediatrics , zoology , pharmacology , biology
Objective Controversy exists regarding the optimal energy prescription to promote successful long‐term behavioral management of obesity. Prescribing intake of 1,000 (vs. 1,500) kcal/day may produce larger initial weight reduction, but long‐term advantage remains unclear. The effects of prescribing 1,000 versus 1,500 kcal/day on 6‐ and 12‐month weight changes within behavioral treatment of obesity were examined. Design and Methods Participants were 125 obese women (mean ± SD; BMI = 37.84 ± 3.94 kg/m 2 ) randomly assigned goals of 1,000 or 1,500 kcal/day. Results From months 0 to 6, participants prescribed 1,000 kcal/day lost more weight than those prescribed 1,500 kcal/day (mean ± SE = −10.03 ± 0.92g vs. −6.23 ± 0.94 kg, P = 0.045); however, from months 7 through 12, only the 1,000 kcal/day condition experienced a significant weight regain (1.51 ± 0.77 kg, P = 0.025). Baseline caloric consumption moderated the effect of treatment on regain; participants with baseline intakes ≧2,000 kcal/day who were assigned 1,000 kcal/day were significantly more susceptible to weight regain than those assigned 1,500 kcal/day ( P = 0.049). At month 12, a significantly greater percentage of 1,000 kcal/day participants achieved weight reductions of 5% or more than those prescribed 1,500 kcal/day. Conclusion Encouraging obese individuals in behavioral treatment to adhere to a 1,000 kcal/day intake may increase their likelihood of achieving clinically meaningful weight losses.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom